• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超高通量膜透析器可改善血液透析患者的死亡率:一项为期3年的全国性队列研究。

Super high-flux membrane dialyzers improve mortality in patients on hemodialysis: a 3-year nationwide cohort study.

作者信息

Abe Masanori, Masakane Ikuto, Wada Atsushi, Nakai Shigeru, Nitta Kosaku, Nakamoto Hidetomo

机构信息

The Committee of Renal Data Registry, Japanese Society for Dialysis Therapy, Tokyo, Japan.

出版信息

Clin Kidney J. 2021 Sep 28;15(3):473-483. doi: 10.1093/ckj/sfab177. eCollection 2022 Mar.

DOI:10.1093/ckj/sfab177
PMID:35211304
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8862063/
Abstract

INTRODUCTION

In Japan, dialyzers are classified based on β-microglobulin clearance. Type I dialyzers are classified as low-flux dialyzers (<10 mL/min clearance), type II and III as high-flux dialyzers (≥10 to <30 mL/min and ≥30 to <50 mL/min clearance, respectively), and type IV and V as super high-flux dialyzers (≥50 to <70 mL/min and ≥70 mL/min clearance, respectively). Super high-flux dialyzers are commonly used, but their superiority over low-flux dialyzers is controversial.

METHODS

In this nationwide prospective cohort study, we analyzed Japanese Society for Dialysis Therapy Renal Data Registry data collected at the end of 2008 and 2011. We enrolled 242,467 patients on maintenance hemodialysis and divided them into five groups by dialyzer type. We assessed the associations of each dialyzer type with 3-year all-cause mortality using Cox proportional hazards models and performed propensity score matching analysis, adjusting for potential confounders.

RESULTS

By the end of 2011, 53,172 (21.9%) prevalent dialysis patients had died. Mortality significantly decreased according to dialyzer type. Hazard ratios (HRs) were significantly higher for type I, II and III compared with type IV (reference) after adjustment for basic factors and further adjustment for dialysis-related factors. HR was significantly higher for type I, but significantly lower for type V, after further adjustment for nutrition- and inflammation-related factors. These significant findings were also evident after propensity score matching.

CONCLUSIONS

Hemodialysis using super high-flux dialyzers might reduce mortality. Randomized controlled trials are warranted to clarify whether these type V dialyzers can improve prognosis.

摘要

引言

在日本,透析器根据β-微球蛋白清除率进行分类。I型透析器被归类为低通量透析器(清除率<10 mL/分钟),II型和III型为高通量透析器(清除率分别≥10至<30 mL/分钟和≥30至<50 mL/分钟),IV型和V型为超高通量透析器(清除率分别≥50至<70 mL/分钟和≥70 mL/分钟)。超高通量透析器被广泛使用,但其相对于低通量透析器的优势存在争议。

方法

在这项全国性前瞻性队列研究中,我们分析了2008年底和2011年底收集的日本透析治疗学会肾脏数据登记处的数据。我们纳入了242,467例维持性血液透析患者,并根据透析器类型将他们分为五组。我们使用Cox比例风险模型评估了每种透析器类型与3年全因死亡率的关联,并进行了倾向评分匹配分析,对潜在混杂因素进行了调整。

结果

到2011年底,53,172例(21.9%)透析患者死亡。死亡率根据透析器类型显著降低。在对基本因素进行调整并进一步对透析相关因素进行调整后,I型、II型和III型的风险比(HRs)与IV型(参照)相比显著更高。在进一步对营养和炎症相关因素进行调整后,I型的HR显著更高,但V型的HR显著更低。这些显著发现在倾向评分匹配后也很明显。

结论

使用超高通量透析器进行血液透析可能会降低死亡率。有必要进行随机对照试验以阐明这些V型透析器是否能改善预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1154/8862063/12f35b8ac306/sfab177fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1154/8862063/fda7e391b238/sfab177fig1g.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1154/8862063/133da20e66e4/sfab177fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1154/8862063/d528dee548ab/sfab177fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1154/8862063/787bec1ed472/sfab177fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1154/8862063/12f35b8ac306/sfab177fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1154/8862063/fda7e391b238/sfab177fig1g.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1154/8862063/133da20e66e4/sfab177fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1154/8862063/d528dee548ab/sfab177fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1154/8862063/787bec1ed472/sfab177fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1154/8862063/12f35b8ac306/sfab177fig4.jpg

相似文献

1
Super high-flux membrane dialyzers improve mortality in patients on hemodialysis: a 3-year nationwide cohort study.超高通量膜透析器可改善血液透析患者的死亡率:一项为期3年的全国性队列研究。
Clin Kidney J. 2021 Sep 28;15(3):473-483. doi: 10.1093/ckj/sfab177. eCollection 2022 Mar.
2
Dialyzer Classification and Mortality in Hemodialysis Patients: A 3-Year Nationwide Cohort Study.血液透析患者的透析器分类与死亡率:一项为期3年的全国性队列研究。
Front Med (Lausanne). 2021 Aug 27;8:740461. doi: 10.3389/fmed.2021.740461. eCollection 2021.
3
High-performance dialyzers and mortality in maintenance hemodialysis patients.高通量透析器与维持性血液透析患者的死亡率。
Sci Rep. 2021 Jun 10;11(1):12272. doi: 10.1038/s41598-021-91751-w.
4
Current dialyzer classification in Japan and mortality risk in patients undergoing hemodialysis.日本目前的透析器分类与血液透析患者的死亡风险。
Sci Rep. 2024 May 4;14(1):10272. doi: 10.1038/s41598-024-60831-y.
5
High-Performance Membrane Dialyzers and Mortality in Hemodialysis Patients: A 2-Year Cohort Study from the Annual Survey of the Japanese Renal Data Registry.高性能膜透析器与血液透析患者死亡率:来自日本肾脏数据登记年度调查的一项为期2年的队列研究
Am J Nephrol. 2017;46(1):82-92. doi: 10.1159/000478032. Epub 2017 Jul 4.
6
Effect of dialyzer membrane materials on survival in chronic hemodialysis patients: Results from the annual survey of the Japanese Nationwide Dialysis Registry.透析器膜材料对慢性血液透析患者生存的影响:日本全国透析登记年度调查结果
PLoS One. 2017 Sep 14;12(9):e0184424. doi: 10.1371/journal.pone.0184424. eCollection 2017.
7
Dialyzer surface area is a significant predictor of mortality in patients on hemodialysis: a 3-year nationwide cohort study.透析器表面积是血液透析患者死亡率的重要预测指标:一项为期 3 年的全国性队列研究。
Sci Rep. 2021 Oct 18;11(1):20616. doi: 10.1038/s41598-021-99834-4.
8
Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.与低通量膜相比,高通量透析器治疗的透析患者中β2微球蛋白与血细胞的结合增加,这导致β2微球蛋白浓度降低。一项交叉研究的结果。
Blood Purif. 2007;25(5-6):432-40. doi: 10.1159/000110069. Epub 2007 Oct 23.
9
National Kidney Foundation report on dialyzer reuse. Task Force on Reuse of Dialyzers, Council on Dialysis, National Kidney Foundation.美国国家肾脏基金会关于透析器复用的报告。透析器复用特别工作组,透析委员会,美国国家肾脏基金会。
Am J Kidney Dis. 1997 Dec;30(6):859-71. doi: 10.1016/s0272-6386(97)90096-2.
10
Rebound kinetics of beta2-microglobulin after hemodialysis.血液透析后β2微球蛋白的反弹动力学
Kidney Int. 1999 Oct;56(4):1571-7. doi: 10.1046/j.1523-1755.1999.00669.x.

引用本文的文献

1
Improved survival with high albumin leakage in patients with protein-energy wasting and inflammation on hemodialysis and online hemodiafiltration.在接受血液透析和在线血液透析滤过治疗的蛋白质能量消耗和炎症患者中,白蛋白高渗漏情况下生存率提高。
Sci Rep. 2025 Aug 1;15(1):28090. doi: 10.1038/s41598-025-07047-w.
2
Management of Chronic Heart Failure in Dialysis Patients: A Challenging but Rewarding Path.透析患者慢性心力衰竭的管理:一条充满挑战但回报丰厚的道路。
Rev Cardiovasc Med. 2024 Jun 25;25(6):232. doi: 10.31083/j.rcm2506232. eCollection 2024 Jun.
3
Current dialyzer classification in Japan and mortality risk in patients undergoing hemodialysis.

本文引用的文献

1
Super high-flux hemodialysis provides comparable effectiveness with high-volume postdilution online hemodiafiltration in removing protein-bound and middle-molecule uremic toxins: A prospective cross-over randomized controlled trial.高通量血液透析与高容量在线血液透析滤过清除蛋白结合和中分子尿毒症毒素的效果相当:一项前瞻性交叉随机对照试验。
Ther Apher Dial. 2021 Feb;25(1):73-81. doi: 10.1111/1744-9987.13508. Epub 2020 Jun 10.
2
Comparison of the removal of uraemic toxins with medium cut-off and high-flux dialysers: a randomized clinical trial.中分子截留和高通量透析器对尿毒症毒素清除效果的比较:一项随机临床试验。
Nephrol Dial Transplant. 2020 Feb 1;35(2):328-335. doi: 10.1093/ndt/gfz189.
3
日本目前的透析器分类与血液透析患者的死亡风险。
Sci Rep. 2024 May 4;14(1):10272. doi: 10.1038/s41598-024-60831-y.
4
Latest Trends in Hemodiafiltration.血液透析滤过的最新趋势
J Clin Med. 2024 Feb 16;13(4):1110. doi: 10.3390/jcm13041110.
5
Middle Molecular Uremic Toxin and Blood Purification Therapy.中分子尿毒症毒素与血液净化疗法
J Clin Med. 2024 Jan 23;13(3):647. doi: 10.3390/jcm13030647.
6
Albumin redox state of maintenance haemodialysis patients is positively altered after treatment.维持性血液透析患者的白蛋白氧化还原状态在治疗后得到正向改变。
BMC Nephrol. 2023 Sep 18;24(1):273. doi: 10.1186/s12882-023-03317-9.
7
High flux novel polymeric membrane for renal applications.高通量新型聚合物膜在肾脏应用中的研究
Sci Rep. 2023 Jul 20;13(1):11703. doi: 10.1038/s41598-023-37765-y.
8
Kinetics of Glucoregulatory Peptide Hormones during Hemodialysis with Cellulose Triacetate and Polysulfone Dialyzers in Patients with Diabetes and End-Stage Kidney Disease.糖尿病和终末期肾病患者使用醋酸纤维素和聚砜透析器进行血液透析时糖调节肽激素的动力学。
Int J Mol Sci. 2023 Jun 25;24(13):10604. doi: 10.3390/ijms241310604.
9
Free Light Chains, High Mobility Group Box 1, and Mortality in Hemodialysis Patients.游离轻链、高迁移率族蛋白B1与血液透析患者的死亡率
J Clin Med. 2022 Nov 23;11(23):6904. doi: 10.3390/jcm11236904.
10
Effectiveness of combination of heat water disinfection, continuous water circulation, and minimalized dead space for dialysis piping in maintaining ultrapure dialysis fluid and preventing biofilm formation in a central dialysis fluid delivery system.组合使用热温水消毒、连续水循环和最小化死腔空间对透析管道进行消毒,以维持超纯透析液并防止中央透析液输送系统中生物膜的形成。
J Artif Organs. 2023 Sep;26(3):220-225. doi: 10.1007/s10047-022-01362-z. Epub 2022 Sep 8.
Cytokine Removal in Extracorporeal Blood Purification: An in vitro Study.
细胞因子在体外血液净化中的清除:一项体外研究。
Blood Purif. 2020;49(1-2):33-43. doi: 10.1159/000502680. Epub 2019 Sep 11.
4
High-permeability alternatives to current dialyzers performing both high-flux hemodialysis and postdilution online hemodiafiltration.替代现行透析器的高通量选择,用于进行高通量血液透析和在线后稀释血液透析滤过。
Artif Organs. 2019 Oct;43(10):1014-1021. doi: 10.1111/aor.13480. Epub 2019 Jun 18.
5
US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States.美国肾脏数据系统2018年年报:美国肾脏疾病流行病学
Am J Kidney Dis. 2019 Mar;73(3 Suppl 1):A7-A8. doi: 10.1053/j.ajkd.2019.01.001. Epub 2019 Feb 21.
6
Dialysis membranes: A 2018 update.透析膜:2018年最新进展
Polim Med. 2018 Jan-Jun;48(1):57-63. doi: 10.17219/pim/102974.
7
Current approaches to middle molecule removal: room for innovation.当前中分子物质清除方法:创新空间。
Nephrol Dial Transplant. 2018 Oct 1;33(suppl_3):iii12-iii21. doi: 10.1093/ndt/gfy224.
8
International Differences in the Location and Use of Arteriovenous Accesses Created for Hemodialysis: Results From the Dialysis Outcomes and Practice Patterns Study (DOPPS).国际间血液透析用动静脉通路位置与使用的差异:来自透析结局和实践模式研究(DOPPS)的结果。
Am J Kidney Dis. 2018 Apr;71(4):469-478. doi: 10.1053/j.ajkd.2017.09.012. Epub 2017 Dec 1.
9
Effect of dialyzer membrane materials on survival in chronic hemodialysis patients: Results from the annual survey of the Japanese Nationwide Dialysis Registry.透析器膜材料对慢性血液透析患者生存的影响:日本全国透析登记年度调查结果
PLoS One. 2017 Sep 14;12(9):e0184424. doi: 10.1371/journal.pone.0184424. eCollection 2017.
10
Comparison of hemodialysis with medium cut-off dialyzer and on-line hemodiafiltration on the removal of small and middle-sized molecules
.采用中截流透析器的血液透析与在线血液透析滤过对中小分子清除效果的比较
Clin Nephrol. 2018 Jan;89 (2018)(1):50-56. doi: 10.5414/CN109133.